[go: up one dir, main page]

AR048811A1 - Uso de toxina botulinica en la preparacion de un medicamento para evitar el crecimiento del vello - Google Patents

Uso de toxina botulinica en la preparacion de un medicamento para evitar el crecimiento del vello

Info

Publication number
AR048811A1
AR048811A1 ARP050100848A ARP050100848A AR048811A1 AR 048811 A1 AR048811 A1 AR 048811A1 AR P050100848 A ARP050100848 A AR P050100848A AR P050100848 A ARP050100848 A AR P050100848A AR 048811 A1 AR048811 A1 AR 048811A1
Authority
AR
Argentina
Prior art keywords
preparation
vello
medicinal product
botulin toxin
avoid growth
Prior art date
Application number
ARP050100848A
Other languages
English (en)
Inventor
Louarn Claude Le
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of AR048811A1 publication Critical patent/AR048811A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

Uso de la toxina botulínica para la preparacion de un medicamento concebido para evitar el crecimiento del vello, y método cosmético para evitar el crecimiento del vello.
ARP050100848A 2004-03-04 2005-03-04 Uso de toxina botulinica en la preparacion de un medicamento para evitar el crecimiento del vello AR048811A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04290582A EP1570855A1 (fr) 2004-03-04 2004-03-04 Utilisation de toxine botulique pour préparer un médicament destiné à prévenir la pousse de poils

Publications (1)

Publication Number Publication Date
AR048811A1 true AR048811A1 (es) 2006-05-31

Family

ID=34746161

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100848A AR048811A1 (es) 2004-03-04 2005-03-04 Uso de toxina botulinica en la preparacion de un medicamento para evitar el crecimiento del vello

Country Status (10)

Country Link
US (1) US7754253B2 (es)
EP (2) EP1570855A1 (es)
JP (1) JP4758981B2 (es)
AR (1) AR048811A1 (es)
AT (1) ATE497780T1 (es)
CA (1) CA2557914C (es)
DE (1) DE602005026259D1 (es)
ES (1) ES2360706T3 (es)
NO (1) NO20064064L (es)
WO (1) WO2005087258A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871224B2 (en) 2003-12-09 2014-10-28 Allergan, Inc. Botulinum toxin therapy for skin disorders
US20050220734A1 (en) 2004-04-02 2005-10-06 Allergan, Inc. Therapy for melanin related afflictions
EP2813239B1 (en) * 2004-08-04 2017-03-22 Ipsen Biopharm Limited Pharmaceutical composition containing botulinum neurotoxin A2
EP1778279B1 (en) * 2004-08-04 2014-12-03 Ipsen Biopharm Limited Pharmaceutical composition containing botulinum neurotoxin a2
CA3045407C (en) 2009-07-29 2024-03-12 Elise A. Olsen Compositions and methods for inhibiting hair growth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562907A (en) * 1993-05-14 1996-10-08 Arnon; Stephen S. Method to prevent side-effects and insensitivity to the therapeutic uses of toxins
US6299893B1 (en) * 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
DE10043982A1 (de) * 2000-09-05 2002-03-14 Armin Maurer Verfahren zur Verbesserung des Haarwuchses menschlichen Kopfhaares
US6831059B2 (en) * 2000-10-20 2004-12-14 Allergan, Inc. Compositions and methods for treating gonadotrophin related illnesses

Also Published As

Publication number Publication date
US7754253B2 (en) 2010-07-13
CA2557914C (fr) 2012-12-04
ATE497780T1 (de) 2011-02-15
EP1722813B1 (fr) 2011-02-09
CA2557914A1 (fr) 2005-09-22
EP1570855A1 (fr) 2005-09-07
JP2007526286A (ja) 2007-09-13
JP4758981B2 (ja) 2011-08-31
EP1722813A1 (fr) 2006-11-22
US20070292546A1 (en) 2007-12-20
ES2360706T3 (es) 2011-06-08
DE602005026259D1 (de) 2011-03-24
WO2005087258A1 (fr) 2005-09-22
WO2005087258A8 (fr) 2006-11-02
NO20064064L (no) 2006-09-25

Similar Documents

Publication Publication Date Title
AR106702A2 (es) Uso de un anticuerpo antagonista anti-ngf para la preparación de un medicamento
CO6640331A2 (es) Tratamiento anti-envejecimiento de la piel
MX2015004636A (es) Motores químicos y métodos para su uso, especialmente en la inyección de fluidos altamente viscosos.
UY27720A1 (es) Aroilpiridinonas monocíclicas,
UY28175A1 (es) Formulaciones farmaceuticas liquidas de palonosetron
MX2011007059A (es) Formulaciones inyectables de toxinas de botulino.
BRPI0910461A8 (pt) hormônio de estimulação do folículo recombinante, sua composição farmacêutica, seu método de produção e seu uso.
DE60204352D1 (de) Haut/haar-äquivalent mit rekonstruierten papillen
EP4321503A4 (en) PEGYLATED LIPID, LIPOSOME THUS MODIFIED, PHARMACEUTICAL COMPOSITION CONTAINING A LIPOSOME, ASSOCIATED PREPARATION AND USE
CL2011002675A1 (es) Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende.
BRPI0512189A (pt) composições e métodos para cuidados com os cabelos
EP4321504A4 (en) PEGYLATED LIPID AND LIPOSOME THUS MODIFIED, PHARMACEUTICAL COMPOSITION COMPRISING A LIPOSOME, ASSOCIATED PREPARATION AND USE
MX2024000895A (es) Composicion farmaceutica que contiene el conjugado del farmaco anticuerpo anti-trop2 y su aplicacion.
CL2008000495A1 (es) Compuestos derivados de tetrahidro-pirazolo[4,3-c]piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como alergias, inflamacion, dolor, cancer, entreotras.
CL2015003145A1 (es) Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmias
AR048811A1 (es) Uso de toxina botulinica en la preparacion de un medicamento para evitar el crecimiento del vello
UY31887A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la cardioversión
UA105944C2 (uk) Комбінація теоброміну з деконгестантом і її застосування для лікування кашлю
WO2014049561A3 (en) Oral composition for reinforcing skin tolerance following topical administration of a retinoid compound
DK1763363T3 (da) Farmaceutiske præparater indeholdende diaminooxidase
ATE433459T1 (de) Desoxo-nonadepsipeptide
DK1869185T3 (da) Konjugat med P21-protein til kræftbehandling
NO20075508L (no) Stannsoporfinpreparater og administrering
ATE424896T1 (de) Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst
DOP2003000601A (es) Aroilpiridinonas monociclicas

Legal Events

Date Code Title Description
FB Suspension of granting procedure